| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,320 | 29,550 | 27,834 | 29,346 | | Cost of Revenue | 4,826 | 4,888 | 5,015 | 6,156 | | | Gross Profit |
-
| 24,662 | 22,819 | 23,190 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,142 | 16,440 | 16,078 | 15,394 | | Non Recurring |
-
| (50) | 50 | (38,345) | | Others | 837 | 3,871 | 1,906 | 70,801 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 4,401 | 4,785 | (24,660) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,515 | 4,401 | 4,785 | (24,660) | | Interest Expense | 793 | 769 | 751 | 1,113 | | Income Before Tax | 4,722 | 3,632 | 4,034 | (25,773) | | Income Tax Expense | 1,313 | 1,004 | 1,067 | (22,631) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,409 | 2,628 | 2,967 | (3,142) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,409 | 2,628 | 2,967 | (3,142) | | Preferred Stock And Other Adjustments | (927) | (925) | (918) | (1,538) | | | Net Income Applicable To Common Shares | $2,482 | $1,703 | $2,049 | ($4,680) |
|
0.51% Nasdaq 
Income Statement
